(Q46569989)

23 December 2017

title

Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients (English)

1 reference

23 December 2017

1 reference

1

1 reference

23 December 2017

August Heidland

6

object named as

August Heidland

1 reference

23 December 2017

author name string

Eva Maria Dette

2

1 reference

23 December 2017

Ursula Schmid

3

1 reference

23 December 2017

Udo Bahner

4

1 reference

23 December 2017

Michaela Winkler

5

1 reference

23 December 2017

Helga Stopper

7

1 reference

23 December 2017

publication date

29 May 2008

1 reference

23 December 2017

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

23 December 2017

volume

378

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

283-291

1 reference

23 December 2017

The HUman MicroNucleus Project--An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00210-008-0310-Y

HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00210-008-0310-Y

Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis

21 January 2018

1 reference

12 December 2020

Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation

1 reference

12 December 2020

Advanced glycation end products: a Nephrologist's perspective

1 reference

12 December 2020

Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose

1 reference

12 December 2020

The effect of convection on the nutritional status of haemodialysis patients.

1 reference

12 December 2020

Genotoxicity of advanced glycation end products in mammalian cells

1 reference

12 December 2020

In vitro evidence for immune activating effect of specific AGE structures retained in uremia

1 reference

12 December 2020

Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy

1 reference

12 December 2020

Impaired DNA repair in patients with end-stage renal disease and its improvement with hemodialysis

1 reference

12 December 2020

Sister chromatid exchange and chromosome abnormalities in uremic patients

1 reference

12 December 2020

Facial skin fluorescence as a marker of the skin's response to chronic environmental insults and its dependence on age.

1 reference

12 December 2020

Antioxidant supplementation reduces inter-individual variation in markers of oxidative damage

1 reference

12 December 2020

High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease

1 reference

12 December 2020

Comparison of the thiamine level in blood and erythrocyte transketolase activity in hemodialyzed and nondialyzed patients during recombinant human erythropoietin therapy.

1 reference

12 December 2020

High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine

1 reference

12 December 2020

Review on uremic toxins: classification, concentration, and interindividual variability

1 reference

12 December 2020

Assessment of DNA strand breakage by the alkaline COMET assay in dialysis patients and the role of Vitamin E supplementation

1 reference

12 December 2020

Oxidative stress in hemodialysis patients: is NADPH oxidase complex the culprit?

1 reference

12 December 2020

Mitochondrial DNA mutations and oxidative damage in skeletal muscle of patients with chronic uremia

1 reference

12 December 2020

Effect of High-Dose Thiamine and Pyridoxine on Advanced Glycation End Products and Other Oxidative Stress Markers in Hemodialysis Patients: A Randomized Placebo-Controlled Study

1 reference

12 December 2020

Chemistry and pathobiology of advanced glycation end products.

1 reference

12 December 2020

Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand

1 reference

12 December 2020

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

1 reference

12 December 2020

Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability--results from a dietary intake and micronucleu

1 reference

12 December 2020

[Incidence and spectrum of malignant disease among dialysis patients in North Bavaria]

1 reference

12 December 2020

Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha

1 reference

12 December 2020

Erythrocyte free radical and energy metabolism

1 reference

12 December 2020

Chorea induced by thiamine deficiency in hemodialysis patients

1 reference

12 December 2020

Micronuclei as a biological endpoint for genotoxicity: A minireview.

1 reference

12 December 2020

1 reference

12 December 2020

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

1 reference

12 December 2020

Micronutrients and genomic stability: a new paradigm for recommended dietary allowances (RDAs).

1 reference

12 December 2020

An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans.

1 reference

12 December 2020

Biochemical and clinical evidence for uremic toxicity

1 reference

12 December 2020

Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients

1 reference

12 December 2020

Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy.

1 reference

12 December 2020

Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA.

1 reference

12 December 2020

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

1 reference

12 December 2020

Profound mishandling of protein glycation degradation products in uremia and dialysis.

1 reference

12 December 2020

Determinants of serum albumin concentration analyzed in a large cohort of patients on maintenance hemodialysis

1 reference

12 December 2020

Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress

1 reference

12 December 2020

Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis

1 reference

12 December 2020

Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients

1 reference

12 December 2020

Cancer in end-stage renal disease: potential factors involved -editorial-

1 reference

12 December 2020

Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes

1 reference

12 December 2020

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

1 reference

12 December 2020

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

1 reference

12 December 2020

8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.

1 reference

12 December 2020

Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells

1 reference

12 December 2020

Biomarkers of DNA damage in patients with end-stage renal disease: mitochondrial DNA mutation in hair follicles

1 reference

12 December 2020

High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus

1 reference

12 December 2020

Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).

1 reference

12 December 2020

Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro

1 reference

12 December 2020

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

1 reference

12 December 2020

Advanced glycation end products in end-stage renal disease and their removal

1 reference

12 December 2020

Advanced glycation endproducts (AGEs) as uremic toxins.

1 reference

12 December 2020

Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy

1 reference

12 December 2020

10.1007/S00210-008-0310-Y

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017